Interleukin-35 induces regulatory B cells that suppress autoimmune disease (original) (raw)

• Edwards, J.C. et al. Efficacy of B cell–targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572–2581 (2004).
  Article CAS Google Scholar
• Hu, C.Y. et al. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 117, 3857–3867 (2007).
  Article CAS Google Scholar
• Yanaba, K. et al. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223, 284–299 (2008).
  Article CAS Google Scholar
• Bouaziz, J.D. et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl. Acad. Sci. USA 104, 20878–20883 (2007).
  Article CAS Google Scholar
• Hamaguchi, Y. Molecular mechanisms of B lymphocyte depletion by CD20 immunotherapy. Nihon Rinsho Meneki Gakkai Kaishi 32, 29–34 (2009).
  Article CAS Google Scholar
• Pers, J.O. et al. B cell depletion and repopulation in autoimmune diseases. Clin. Rev. Allergy Immunol. 34, 50–55 (2008).
  Article CAS Google Scholar
• Bouaziz, J.D., Yanaba, K. & Tedder, T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224, 201–214 (2008).
  Article CAS Google Scholar
• Yanaba, K. et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell–dependent inflammatory responses. Immunity 28, 639–650 (2008).
  Article CAS Google Scholar
• Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221–241 (2012).
  Article CAS Google Scholar
• Tadmor, T., Zhang, Y., Cho, H.M., Podack, E.R. & Rosenblatt, J.D. The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol. Immunother. 60, 609–619 (2011).
  Article CAS Google Scholar
• Schioppa, T. et al. B regulatory cells and the tumor-promoting actions of TNF-a during squamous carcinogenesis. Proc. Natl. Acad. Sci. USA 108, 10662–10667 (2011).
  Article CAS Google Scholar
• Mauri, C. & Ehrenstein, M.R. The 'short' history of regulatory B cells. Trends Immunol. 29, 34–40 (2008).
  Article CAS Google Scholar
• Berthelot, J.M. et al. Regulatory B cells play a key role in immune system balance. Joint Bone Spine 80, 18–22 (2013).
  Article CAS Google Scholar
• Yoshizaki, A. et al. Regulatory B cells control T cell autoimmunity through IL-21–dependent cognate interactions. Nature 491, 264–268 (2012).
  Article CAS Google Scholar
• Rafei, M. et al. A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat. Med. 15, 1038–1045 (2009).
  Article CAS Google Scholar
• Collison, L.W. et al. The inhibitory cytokine IL-35 contributes to regulatory T cell function. Nature 450, 566–569 (2007).
  Article CAS Google Scholar
• Collison, L.W. et al. IL-35–mediated induction of a potent regulatory T cell population. Nat. Immunol. 11, 1093–1101 (2010).
  Article CAS Google Scholar
• Hunter, C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521–531 (2005).
  Article CAS Google Scholar
• Devergne, O., Birkenbach, M. & Kieff, E. Epstein-Barr virus–induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc. Natl. Acad. Sci. USA 94, 12041–12046 (1997).
  Article CAS Google Scholar
• Niedbala, W. et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 37, 3021–3029 (2007).
  Article CAS Google Scholar
• Caspi, R.R. A look at autoimmunity and inflammation in the eye. J. Clin. Invest. 120, 3073–3083 (2010).
  Article CAS Google Scholar
• Fillatreau, S., Gray, D. & Anderton, S.M. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol. 8, 391–397 (2008).
  Article CAS Google Scholar
• Carter, N.A. et al. Mice lacking endogenous IL-10–producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186, 5569–5579 (2011).
  Article CAS Google Scholar
• Ding, Q. et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121, 3645–3656 (2011).
  Article CAS Google Scholar
• Nussenblatt, R.B. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 32, 3131–3141 (1991).
  CAS PubMed Google Scholar
• Caspi, R.R. et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490–1495 (1988).
  CAS PubMed Google Scholar
• Vasconcellos, R., Carter, N.A., Rosser, E.C. & Mauri, C. IL-12p35 subunit contributes to autoimmunity by limiting IL-27–driven regulatory responses. J. Immunol. 187, 3402–3412 (2011).
  Article CAS Google Scholar
• Collison, L.W. et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 13, 290–299 (2012).
  Article CAS Google Scholar
• Tarrant, T.K., Silver, P.B., Chan, C.C., Wiggert, B. & Caspi, R.R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161, 122–127 (1998).
  CAS PubMed Google Scholar
• Egwuagu, C.E., Charukamnoetkanok, P. & Gery, I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 159, 3109–3112 (1997).
  CAS PubMed Google Scholar
• Shen, P. et al. IL-35–producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366–370 (2014).
  Article CAS Google Scholar
• Vignali, D.A. & Kuchroo, V.K. IL-12 family cytokines: immunological playmakers. Nat. Immunol. 13, 722–728 (2012).
  Article CAS Google Scholar
• Wang, R.X., Yu, C.R., Mahdi, R.M. & Egwuagu, C.E. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells. J. Biol. Chem. 287, 36012–36021 (2012).
  Article CAS Google Scholar
• Stumhofer, J.S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119–1126 (2010).
  Article CAS Google Scholar
• Nussenblatt, R.B. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int. Rev. Immunol. 21, 273–289 (2002).
  Article Google Scholar
• Olkhanud, P.B. et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4 T cells to T-regulatory cells. Cancer Res. 71, 3505–3515 (2011).
  Article CAS Google Scholar
• Liu, X., Lee, Y.S., Yu, C.R. & Egwuagu, C.E. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180, 6070–6076 (2008).
  Article CAS Google Scholar
• Takase, H. et al. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 168, 118–127 (2005).
  Article CAS Google Scholar
• Oh, H.M. et al. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J. Immunol. 187, 3338–3346 (2011).
  Article CAS Google Scholar
• Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D. & Anderton, S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944–950 (2002).
  Article CAS Google Scholar
• Paques, M. et al. Panretinal, high-resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci. 48, 2769–2774 (2007).
  Article Google Scholar
• Xu, H. et al. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 87, 319–326 (2008).
  Article CAS Google Scholar
• Chan, C.C. et al. Pathology of experimental autoimmune uveoretinitis in mice. J. Autoimmun. 3, 247–255 (1990).
  Article CAS Google Scholar
• Amadi-Obi, A. et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat. Med. 13, 711–718 (2007).
  Article CAS Google Scholar
• Yu, C.R., Lee, Y.S., Mahdi, R.M., Surendran, N. & Egwuagu, C.E. Therapeutic targeting of STAT3 (signal transducers and activators of transcription 3) pathway inhibits experimental autoimmune uveitis. PLoS ONE 7, e29742 (2012).
  Article CAS Google Scholar
• Li, W., Nagineni, C.N., Hooks, J.J., Chepelinsky, A.B. & Egwuagu, C.E. Interferon-g signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors. Invest. Ophthalmol. Vis. Sci. 40, 976–982 (1999).
  CAS PubMed Google Scholar
• Oh, H.M. et al. STAT3 protein promotes T cell survival and inhibits interleukin-2 production through up-regulation of class O Forkhead transcription factors. J. Biol. Chem. 286, 30888–30897 (2011).
  Article CAS Google Scholar